These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35811515)

  • 21. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.
    Robbins TW; James M; Owen AM; Lange KW; Lees AJ; Leigh PN; Marsden CD; Quinn NP; Summers BA
    J Neurol Neurosurg Psychiatry; 1994 Jan; 57(1):79-88. PubMed ID: 8301310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Executive dysfunction, behavioral changes and quality of life in Chinese patients with progressive supranuclear palsy.
    Ou R; Liu H; Hou Y; Wei Q; Cao B; Zhao B; Shang H
    J Neurol Sci; 2017 Sep; 380():182-186. PubMed ID: 28870563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
    Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.
    Gerstenecker A; Mast B; Duff K; Ferman TJ; Litvan I;
    Arch Clin Neuropsychol; 2013 Mar; 28(2):104-13. PubMed ID: 23127882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration.
    Gerstenecker A
    Arch Clin Neuropsychol; 2017 Nov; 32(7):861-875. PubMed ID: 28961692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Brain; 2006 Apr; 129(Pt 4):1040-9. PubMed ID: 16455792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report].
    Morishima R; Bandoh M; Sunami Y; Isozaki E
    Rinsho Shinkeigaku; 2019 Nov; 59(11):730-735. PubMed ID: 31656263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy.
    Daniele A; Barbier A; Di Giuda D; Vita MG; Piccininni C; Spinelli P; Tondo G; Fasano A; Colosimo C; Giordano A; Gainotti G
    Cortex; 2013 Apr; 49(4):948-60. PubMed ID: 22683271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Social cognitive deficits and their neural correlates in progressive supranuclear palsy.
    Ghosh BC; Calder AJ; Peers PV; Lawrence AD; Acosta-Cabronero J; Pereira JM; Hodges JR; Rowe JB
    Brain; 2012 Jul; 135(Pt 7):2089-102. PubMed ID: 22637582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional microstructural damage and patterns of eye movement impairment: a DTI and video-oculography study in neurodegenerative parkinsonian syndromes.
    Gorges M; Maier MN; Rosskopf J; Vintonyak O; Pinkhardt EH; Ludolph AC; Müller HP; Kassubek J
    J Neurol; 2017 Sep; 264(9):1919-1928. PubMed ID: 28762086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment in progressive supranuclear palsy is associated with tau burden.
    Koga S; Parks A; Kasanuki K; Sanchez-Contreras M; Baker MC; Josephs KA; Ahlskog JE; Uitti RJ; Graff-Radford N; van Gerpen JA; Wszolek ZK; Rademakers R; Dickson DW
    Mov Disord; 2017 Dec; 32(12):1772-1779. PubMed ID: 29082658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower urinary tract dysfunction in Parkinsonian syndromes.
    Vichayanrat E; Hentzen C; Batla A; Simeoni S; Iodice V; Panicker JN
    Neurol Sci; 2021 Oct; 42(10):4045-4054. PubMed ID: 34318363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
    Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA
    Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy.
    Brenneis C; Seppi K; Schocke M; Benke T; Wenning GK; Poewe W
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):246-9. PubMed ID: 14742598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
    Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
    Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ; Siuda J
    Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).
    Bak TH; Crawford LM; Hearn VC; Mathuranath PS; Hodges JR
    Neurocase; 2005 Aug; 11(4):268-73. PubMed ID: 16093227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
    Horta-Barba A; Pagonabarraga J; Martínez-Horta S; Busteed L; Pascual-Sedano B; Illán-Gala I; Marin-Lahoz J; Aracil-Bolaños I; Pérez-Pérez J; Sampedro F; Bejr-Kasem H; Kulisevsky J
    J Neurol; 2021 Sep; 268(9):3400-3408. PubMed ID: 33704556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy.
    Tomše P; Rebec E; Studen A; Perovnik M; Rus T; Ležaić L; Tang CC; Eidelberg D; Trošt M
    Phys Med; 2022 Jun; 98():131-138. PubMed ID: 35537328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.